As we approach the mid-year mark, I wanted to share a few updates on the progress of our 2025 initiatives. From day one, the Scleroderma Research Foundation’s commitment to accelerating research has never wavered. Our mission to end this disease remains clear—which is why this year, we’ve prioritized major new research investments and vital collaborations among leading investigators.
This work is at the core of our mission, and it’s only possible thanks to the unstoppable support of the scleroderma community. We’re proud to share the impact your partnership is having on our research efforts:
These are just a few ways your steadfast support is driving meaningful progress to end this disease. There’s still much work ahead—but today, a cure is closer than ever. Together, we will achieve our vision: a world free from scleroderma.
Warmly,
Joanne Gold
Executive Director
Scleroderma Research Foundation